Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1989 Oct;98(2):637–645. doi: 10.1111/j.1476-5381.1989.tb12638.x

Enhancement of leukotriene C4 release from primate airway macrophages by cellular interactions.

A M Campbell 1, S T Harper 1, C Hallam 1, E Wells 1, J Mann 1, C Robinson 1
PMCID: PMC1854743  PMID: 2819337

Abstract

1. Cells were obtained from the lungs of Macaque monkeys by bronchoalveolar lavage in order to study the role of cellular interactions in the release of leukotriene C4 (LTC4). 2. In normal monkeys, macrophages were the most abundant cell type recovered, whereas in monkeys sensitized with Ascaris suum there was an increase in the numbers of eosinophils and mast cells recovered. 3. Challenge of cells from both groups of animals with an optimal concentration of opsonized zymosan (OPZ) resulted in the time-dependent release of LTC4 from macrophages. However, release was significantly greater in cells obtained from sensitized donors compared to normal donors. 4. Density-gradient centrifugation of cells lavaged from sensitized donors was used to prepare fractions containing both eosinophils and mast cells. Addition of these cells to macrophage populations obtained from non-sensitized donors caused a significant enhancement of OPZ-induced LTC4 release. In the absence of macrophages no significant release of LTC4 was detected from eosinophil/mast cell-containing fractions stimulated with OPZ, despite the fact that the zymosan had been phagocytosed by the eosinophils. 5. There was a significant correlation between the percentage enhancement of LTC4 release and the number of eosinophils added. However, there was not a significant correlation with the number of mast cells added. 6. These results suggest that a cellular interaction between macrophages and eosinophils may be important in the regulation of mediator synthesis and release. The precise mechanism of this effect remains to be elucidated.

Full text

PDF
637

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albrightson C. R., Baenziger N. L., Needleman P. Exaggerated human vascular cell prostaglandin biosynthesis mediated by monocytes: role of monokines and interleukin 1. J Immunol. 1985 Sep;135(3):1872–1877. [PubMed] [Google Scholar]
  2. Ambler J., Doe J. E., Gemmell D. K., Roberts J. A., Orr T. S. Biological techniques for studying the allergenic components of nematodes. I. Detection of allergenic components in Ascaris suum extracts. J Immunol Methods. 1972 Aug;1(4):317–328. doi: 10.1016/0022-1759(72)90025-7. [DOI] [PubMed] [Google Scholar]
  3. Beaven M. A., Jacobsen S., Horáková Z. Modification of the enzymatic isotopic assay of histamine and its application to measurement of histamine in tissues, serum and urine. Clin Chim Acta. 1972 Mar;37:91–103. doi: 10.1016/0009-8981(72)90419-6. [DOI] [PubMed] [Google Scholar]
  4. Bonta I. L., Parnham M. J. Immunomodulatory-antiinflammatory functions of E-type prostaglandins. Minireview with emphasis on macrophage-mediated effects. Int J Immunopharmacol. 1982;4(2):103–109. doi: 10.1016/0192-0561(82)90057-1. [DOI] [PubMed] [Google Scholar]
  5. Bruynzeel P. L., Kok P. T., Hamelink M. L., Kijne A. M., Verhagen J. Exclusive leukotriene C4 synthesis by purified human eosinophils induced by opsonized zymosan. FEBS Lett. 1985 Sep 23;189(2):350–354. doi: 10.1016/0014-5793(85)81054-1. [DOI] [PubMed] [Google Scholar]
  6. Dessein A. J., Lee T. H., Elsas P., Ravalese J., 3rd, Silberstein D., David J. R., Austen K. F., Lewis R. A. Enhancement by monokines of leukotriene generation by human eosinophils and neutrophils stimulated with calcium ionophore A23187. J Immunol. 1986 May 15;136(10):3829–3838. [PubMed] [Google Scholar]
  7. Dessein A. J., Lenzi H. L., Bina J. C., Carvalho E. M., Weiser W. Y., Andrade Z. A., David J. R. Modulation of eosinophil cytotoxicity by blood mononuclear cells from healthy subjects and patients with chronic schistosomiasis mansoni. Cell Immunol. 1984 Apr 15;85(1):100–113. doi: 10.1016/0008-8749(84)90282-x. [DOI] [PubMed] [Google Scholar]
  8. Dessein A. J., Lenzi H. L., David J. R. Modulation of the cytotoxicity of human blood eosinophils by factors secreted by monocytes and T lymphocytes. Monogr Allergy. 1983;18:45–51. [PubMed] [Google Scholar]
  9. Greenberg G., Burnstock G. A novel cell-to-cell interaction between mast cells and other cell types. Exp Cell Res. 1983 Aug;147(1):1–13. doi: 10.1016/0014-4827(83)90265-3. [DOI] [PubMed] [Google Scholar]
  10. Henson P. M., Johnston R. B., Jr Tissue injury in inflammation. Oxidants, proteinases, and cationic proteins. J Clin Invest. 1987 Mar;79(3):669–674. doi: 10.1172/JCI112869. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hunninghake G. W., Gadek J. E., Fales H. M., Crystal R. G. Human alveolar macrophage-derived chemotactic factor for neutrophils. Stimuli and partial characterization. J Clin Invest. 1980 Sep;66(3):473–483. doi: 10.1172/JCI109878. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hunninghake G. W., Gadek J. E., Lawley T. J., Crystal R. G. Mechanisms of neutrophil accumulation in the lungs of patients with idiopathic pulmonary fibrosis. J Clin Invest. 1981 Jul;68(1):259–269. doi: 10.1172/JCI110242. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kimura I., Moritani Y., Tanizaki Y. Basophils in bronchial asthma with reference to reagin-type allergy. Clin Allergy. 1973 Jun;3(2):195–202. doi: 10.1111/j.1365-2222.1973.tb01321.x. [DOI] [PubMed] [Google Scholar]
  14. Lee T. H. Interactions between alveolar macrophages, monocytes, and granulocytes. Implications for airway inflammation. Am Rev Respir Dis. 1987 Jun;135(6 Pt 2):S14–S17. doi: 10.1164/arrd.1987.135.6P2.S14. [DOI] [PubMed] [Google Scholar]
  15. Lenzi H. L., Mednis A. D., Dessein A. J. Activation of human eosinophils by monokines and lymphokines: source and biochemical characteristics of the eosinophil cytotoxicity-enhancing activity produced by blood mononuclear cells. Cell Immunol. 1985 Sep;94(2):333–346. doi: 10.1016/0008-8749(85)90257-6. [DOI] [PubMed] [Google Scholar]
  16. MacGlashan D. W., Jr, Schleimer R. P., Peters S. P., Schulman E. S., Adams G. K., 3rd, Newball H. H., Lichtenstein L. M. Generation of leukotrienes by purified human lung mast cells. J Clin Invest. 1982 Oct;70(4):747–751. doi: 10.1172/JCI110670. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Mahauthaman R., Howell C. J., Spur B. W., Youlten L. J., Clark T. J., Lessof M. H., Lee T. H. The generation and cellular distribution of leukotriene C4 in human eosinophils stimulated by unopsonized zymosan and glucan particles. J Allergy Clin Immunol. 1988 Apr;81(4):696–705. doi: 10.1016/0091-6749(88)91041-x. [DOI] [PubMed] [Google Scholar]
  18. Merrill W. W., Naegel G. P., Matthay R. A., Reynolds H. Y. Alveolar macrophage-derived chemotactic factor: kinetics of in vitro production and partial characterization. J Clin Invest. 1980 Feb;65(2):268–276. doi: 10.1172/JCI109668. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Murphy R. C., Henson P. M. Mediator network. Ann Inst Pasteur Immunol. 1985 Sep-Oct;136D(2):219–221. doi: 10.1016/s0769-2625(85)80105-7. [DOI] [PubMed] [Google Scholar]
  20. Okusawa S., Gelfand J. A., Ikejima T., Connolly R. J., Dinarello C. A. Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition. J Clin Invest. 1988 Apr;81(4):1162–1172. doi: 10.1172/JCI113431. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Owen W. F., Jr, Soberman R. J., Yoshimoto T., Sheffer A. L., Lewis R. A., Austen K. F. Synthesis and release of leukotriene C4 by human eosinophils. J Immunol. 1987 Jan 15;138(2):532–538. [PubMed] [Google Scholar]
  22. Paterson N. A., Wasserman S. I., Said J. W., Austen K. F. Release of chemical mediators from partially purified human lung mast cells. J Immunol. 1976 Oct;117(4):1356–1362. [PubMed] [Google Scholar]
  23. Pennington J. E., Rossing T. H., Boerth L. W., Lee T. H. Isolation and partial characterization of a human alveolar macrophage-derived neutrophil-activating factor. J Clin Invest. 1985 Apr;75(4):1230–1237. doi: 10.1172/JCI111820. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Pennington J. E., Rossing T. H., Boerth L. W. The effect of human alveolar macrophages on the bactericidal capacity of neutrophils. J Infect Dis. 1983 Jul;148(1):101–109. doi: 10.1093/infdis/148.1.101. [DOI] [PubMed] [Google Scholar]
  25. Peters S. P., MacGlashan D. W., Jr, Schulman E. S., Schleimer R. P., Hayes E. C., Rokach J., Adkinson N. F., Jr, Lichtenstein L. M. Arachidonic acid metabolism in purified human lung mast cells. J Immunol. 1984 Apr;132(4):1972–1979. [PubMed] [Google Scholar]
  26. Silberstein D. S., Owen W. F., Gasson J. C., DiPersio J. F., Golde D. W., Bina J. C., Soberman R., Austen K. F., David J. R. Enhancement of human eosinophil cytotoxicity and leukotriene synthesis by biosynthetic (recombinant) granulocyte-macrophage colony-stimulating factor. J Immunol. 1986 Nov 15;137(10):3290–3294. [PubMed] [Google Scholar]
  27. Vadas M. A., Nicola N., Lopez A. F., Metcalf D., Johnson G., Pereira A. Mononuclear cell-mediated enhancement of granulocyte function in man. J Immunol. 1984 Jul;133(1):202–207. [PubMed] [Google Scholar]
  28. Varsano S., Lazarus S. C., Gold W. M., Nadel J. A. Selective adhesion of mast cells to tracheal epithelial cells in vitro. J Immunol. 1988 Apr 1;140(7):2184–2192. [PubMed] [Google Scholar]
  29. Veith M. C., Butterworth A. E. Enhancement of human eosinophil-mediated killing of Schistosoma mansoni larvae by mononuclear cell products in vitro. J Exp Med. 1983 Jun 1;157(6):1828–1843. doi: 10.1084/jem.157.6.1828. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Wells E., Harper S. T., Jackson C. G., Mann J., Eady R. P. Characterization of primate bronchoalveolar mast cells. I. IgE-dependent release of histamine, leukotrienes, and prostaglandins. J Immunol. 1986 Dec 15;137(12):3933–3940. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES